Table 1.
Distribution of Chron’s disease (CD) patients according to demographic data.
| No. | % | |
|---|---|---|
| Sex | ||
| Male | 31 | 67.4 |
| Female | 15 | 32.6 |
| Age | ||
| Range | 18.0–70.0 | |
| Mean ± SD | 30.43 ± 10.20 | |
| Smoking | ||
| No | 39 | 84.8 |
| Yes | 7 | 15.2 |
| Family IBD Hx | ||
| No | 37 | 80.4 |
| Yes | 9 | 19.6 |
| Complication | ||
| No not for surgery | 23 | 50.0 |
| Yes for surgery | 23 | 50.0 |
| Phenotype | ||
| Fistulizing | 22 | 47.8 |
| Fibrostenotic | 7 | 15.2 |
| Inflammatory | 16 | 34.8 |
| Fistulizing & Fibrostenotic | 1 | 2.2 |
| Presenting symptoms | ||
| Abdominal pain | 38 | 86.4 |
| Anemia | 7 | 15.9 |
| Arthritis | 6 | 13.6 |
| Bleeding per rectum | 19 | 43.2 |
| Diarrhea | 33 | 75.0 |
| Eye disease | 3 | 6.8 |
| Fever | 10 | 22.7 |
| Perianal Disease | 16 | 36.4 |
| Skin lesions | 4 | 9.1 |
| Vomiting | 6 | 13.6 |
| Weight loss | 24 | 54.5 |
| Medications | ||
| 5-ASA | 23 | 51.1 |
| Adalimumab | 3 | 6.7 |
| Budesonide | 3 | 6.7 |
| Imuran | 35 | 77.8 |
| Infliximab | 28 | 62.2 |
| Steroid | 12 | 26.7 |
| Disease extent | ||
| Ileal | 10 | 21.7 |
| Ileocolonic | 27 | 58.7 |
| Colonic | 9 | 19.6 |